Monitoring the Crosstalk Between the Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 with PET

PURPOSE: Ovarian cancer (OC) leads to poor survival rates mainly due to late stage detection and innate or acquired resistance to chemotherapy. Thus, efforts have been made to exploit the estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) to treat OC. However, patients eventu...

Descripción completa

Detalles Bibliográficos
Autores principales: Antunes, I. F., Hospers, G. A. P., Sijbesma, J. W. A., Boerema, A. S., van Waarde, A., Glaudemans, A. W. J. M, Dierckx, R. A. J. O., de Vries, E. G. E., de Vries, E. F. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497457/
https://www.ncbi.nlm.nih.gov/pubmed/32285356
http://dx.doi.org/10.1007/s11307-020-01496-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497457/
https://www.ncbi.nlm.nih.gov/pubmed/32285356
http://dx.doi.org/10.1007/s11307-020-01496-7

Ejemplares similares